• Publications
  • Influence
Prevalence of kidney damage in Australian adults: The AusDiab kidney study.
The incidence of ESRD is increasing dramatically. Progression to end-stage may be halted or slowed when kidney damage is detected at an early stage. Kidney damage is frequently asymptomatic but isExpand
  • 689
  • 27
Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
BACKGROUND Abnormalities in serum calcium, phosphorus, and parathyroid hormone (PTH) concentrations are common in patients with chronic kidney disease and have been associated with increasedExpand
  • 789
  • 27
Vascular access and all-cause mortality: a propensity score analysis.
The native arteriovenous fistula (AVF) is the preferred vascular access because of its longevity and its lower rates of infection and intervention. Recent studies suggest that the AVF may offer aExpand
  • 401
  • 16
Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease.
BACKGROUND Vascular calcification (VC) and arterial stiffness are major contributors to cardiovascular (CV) disease in chronic kidney disease (CKD). Both are independent predictors of CV mortalityExpand
  • 214
  • 15
Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS).
BACKGROUND Anemia is common in hemodialysis (HD) patients. METHODS Data collected from nationally representative samples of HD patients (n = 11,041) in 2002 to 2003 were used to describe currentExpand
  • 353
  • 14
Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS).
BACKGROUND Mineral metabolism has emerged as an important predictor of morbidity and mortality in dialysis patients, independent of bone and muscle concerns. Several expert panels have issuedExpand
  • 308
  • 14
Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy.
Using data from the international Dialysis Outcomes and Practice Patterns Study (DOPPS), we determined incidence, prevalence, and outcomes among hemodialysis patients with atrial fibrillation. CoxExpand
  • 196
  • 8
Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial.
OBJECTIVES The Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) aimed to establish whether high-dose folic acid would slow the progression of atherosclerosis and reduce cardiovascularExpand
  • 224
  • 8
Transition from pediatric to adult renal services: a consensus statement by the International Society of Nephrology (ISN) and the International Pediatric Nephrology Association (IPNA)
The transfer of young patients from pediatric to adult renal care takes place after a transition process which involves both sides. It is important that it is individualized for each young person,Expand
  • 136
  • 8
Home haemodialysis in Australia - is the wheel turning full circle?
In the mid 1970s, home haemodialysis accounted for nearly half of all patients on dialysis, both in Australia and elsewhere. The advent of both peritoneal dialysis (itself a home therapy) andExpand
  • 32
  • 8